Tarsus Pharmaceuticals, Inc.

8-K Director or officer change Jul 13, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 8, 2026 8-K Shareholder vote results Jun 29, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 23, 2026 8-K Results of operations (earnings release) Feb 23, 2026 8-K Director or officer change Feb 18, 2026 8-K Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Other events Mar 18, 2025 8-K Entered a material agreement; Other events Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Director or officer change Jan 17, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Entered a material agreement Dec 19, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Director or officer change Nov 5, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 18, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Apr 23, 2024 8-K Other events Mar 5, 2024 8-K Entered a material agreement; Other events Mar 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Director or officer change Jan 18, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Other events Dec 11, 2023 8-K Results of operations (earnings release) Nov 9, 2023